This paper is in the following e-collection/theme issue:

Systematic Review Protocols (303) Diabetes (234) Prevention and Health Promotion (1165) Cardiovascular Disease Prevention (173) Diabetes Self-Management (545) Psychological, -behavioural, -social, and/or -cultural Experiments and Interventions (68)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/53517, first published .
Effects of Lifestyle Interventions on Cardiovascular Disease Risk and Risk Factors Among Individuals at High Risk for Type 2 Diabetes: Protocol for a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of Lifestyle Interventions on Cardiovascular Disease Risk and Risk Factors Among Individuals at High Risk for Type 2 Diabetes: Protocol for a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Effects of Lifestyle Interventions on Cardiovascular Disease Risk and Risk Factors Among Individuals at High Risk for Type 2 Diabetes: Protocol for a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Authors of this article:

Getu Debalkie Demissie1, 2 Author Orcid Image ;   Josephine Birungi1, 2 Author Orcid Image ;   Tilahun Haregu2, 3 Author Orcid Image ;   Sathish Thirunavukkarasu2, 4, 5 Author Orcid Image ;   Brian Oldenburg1, 2 Author Orcid Image
Article Authors Cited by (1) Tweetations (1) Metrics

Journals

  1. Dong J, Yang X, Zhang W. Letter by Dong et al Regarding Article, “Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation”. Circulation 2025;151(17) View